High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III

Current Microbiology

Volumn 54, Issue 1, 2007, Pages 42-47

  Palacios, Gerardo C ^a   Gonzalez, Maria N ^a   Beltran, Magdalena ^b   Arredondo, Jose L ^b   Torres, Javier ^a   Solorzano, Fortino ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; HIGH TEMPERATURE; MEXICO; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

ADULT; CARRIER STATE; CULTURE MEDIA; HUMANS; INFANT, NEWBORN; MEXICO; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TEMPERATURE; VIRULENCE;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 33845797093     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-006-0291-3     Document Type: Article

References (26)

1. Baker CJ, Edwards MS (1995) Group B. Streptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, pp 980-1054
2. Musser JM, Mattingly SJ, Quentin R, et al. (1989) Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 86:4731-4735
3. Hauge M, Jespersgaard C, Poulsen K, et al. (1996) Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect Immun 64:919-925
4. Quentin R, Huet H, Wang F, et al. (1995) Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 33:2576-2581
5. Fleming KE, Bohnsack JF, Palacios GC, et al. (2004) Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS). J Med Microbiol 53:1-4
6. Helmig R, Uldbjerg N, Boris J, et al. (1993) Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women. J Infect Dis 168:904-009
7. Mattingly SJ, Maurer JJ, Eskew EK, et al. (1990) Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40°C. J Clin Microbiol 28:1676-1677
8. Mattingly SJ, Eskew KE (1993) Temperature sensitivity of fructose-1,6-bisphosphate aldolase accounts for the inability of the high-virulence clone of Streptococcus agalactiae to grow at 40°C. Curr Microbiol 26:147-150
9. Palacios GC, Eskew EK, Solorzano F, et al. (1999) Identification of the high-virulence clone of group B streptococci in Mexican isolates by growth characteristics at 40°C. Curr Microbiol 38:126-131
10. Takahashi S, Adderson EE, Nagano Y, et al. (1998) Identification of a highly encapsulated, genetically related group of invasive type III group B streptocci. J Infect Dis 177:1116-1119
11. Jones N, Bohnsack JF, Takahashi S, et al. (2003) Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 41:2530-2536
12. Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, NorgrenM (2005) Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 43:3727-3733
13. Palacios GC, Timmons BC, Eskew EK, et al. (2003) Identification of the high-virulence clone of group B streptococci by using a probe containing a putative aldolase gene. Curr Microbiol 47:319-322
14. Palacios GC, Eskew EK, Solorzano F, et al. (1997) Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico. J Clin Microbiol 35:2923-2926
15. Milligan TW, Doran TI, Straus DC, et al. (1978) Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol 7:28-33
16. Terleckyj B, Willett NP, Shockman GD (1975) Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun 11:649-655
17. Lang TA, Secic M (1997) How to report statistics in medicine. Annotated guidelines for authors, editors, and reviewers. Philadelphia: American College of Physicians
18. Takahashi S, Detrick S, Whiting AA, et al. (2002) Correlation of phylogenetic lineages of group B streptococci, identified by analysis of restriction-digest patterns of genomic DNA with infB alleles and mobile genetic elements. J Infect Dis 186:1034-1038
19. Maurer JJ, Mattingly SJ (1988) In vitro method to differentiate isolates of Streptococcus agalactiae from symptomatic and asymptomatic patients. J Clin Microbiol 26:686-691
20. Solorzano-Santos F, Echaniz-Aviles G, Conde-Gonzalez CJ, et al. (1989) Cervicovaginal infection with group B streptococci among pregnant Mexican women. J Infect Dis 159:1003-1004
21. Solorzano-Santos F, Diaz-Ramos RD, Arredondo-García JL (1990) Diseases caused by group B Streptococcus in Mexico. Pediatr Infect Dis J 9:66
22. Palacios-Saucedo G, Caltenco-Serrano R, Torres-Lopez J, et al. (2002) Exposición a Estreptococo del grupo B en mujeres mexicanas en edad reproductiva. Salud Pub Mex 44:50-56
23. Villaseñor-Sierra A, Morales-Velázquez P, Palacios-Saucedo G, Solórzano-Santos F (2004) Prevalencia de Streptococcus agalactiae del serotipo III en embarazadas. Ginecol Obstet Mex 72:103-108
24. Doran TI, Straus DC, Mattingly SJ (1981) Factors influencing release of type III antigens by group B streptococci. Infect Immun 31:615-623
25. Milligan TW, Baker CJ, Straus DC, et al. (1978) Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun 21:738-746
26. Nealon TJ, Mattingly SJ (1983) Association of elevated levels of cellular lipoteichoic acid of group B streptococci with human neonatal disease. Infect Immun 39:1243-1251